STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 69 filers reported holding STEMLINE THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $647,000 | -1.2% | 60,500 | 0.0% | 0.02% | 0.0% |
| Q3 2016 | $655,000 | +60.1% | 60,500 | 0.0% | 0.02% | +58.3% |
| Q2 2016 | $409,000 | +45.0% | 60,500 | 0.0% | 0.01% | +33.3% |
| Q1 2016 | $282,000 | -26.2% | 60,500 | 0.0% | 0.01% | -25.0% |
| Q4 2015 | $382,000 | -28.5% | 60,500 | 0.0% | 0.01% | -45.5% |
| Q3 2015 | $534,000 | -25.0% | 60,500 | 0.0% | 0.02% | -15.4% |
| Q2 2015 | $712,000 | +115.8% | 60,500 | +165.4% | 0.03% | +116.7% |
| Q1 2015 | $330,000 | -15.2% | 22,800 | 0.0% | 0.01% | -33.3% |
| Q4 2014 | $389,000 | +37.0% | 22,800 | 0.0% | 0.02% | +63.6% |
| Q3 2014 | $284,000 | – | 22,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lyon Street Capital, LLC | 762,941 | $7,248,000 | 7.29% |
| NEXTHERA CAPITAL LP | 711,558 | $6,760,000 | 2.79% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 585,930 | $4,366,000 | 2.71% |
| Consonance Capital Management LP | 1,155,793 | $10,980,000 | 0.81% |
| Pier Capital, LLC | 423,667 | $4,025,000 | 0.80% |
| KNOTT DAVID M | 155,795 | $1,480,000 | 0.70% |
| Eventide Asset Management | 1,086,400 | $10,321,000 | 0.46% |
| Empire Life Investments Inc. | 373,863 | $3,552,000 | 0.32% |
| Telemetry Investments, L.L.C. | 41,588 | $395,000 | 0.25% |
| Polar Capital LLP | 2,302,666 | $21,875,000 | 0.23% |